Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for painful bandage changes in rare skin disease

NCT ID NCT03730584

First seen Nov 20, 2025 · Last updated Jun 18, 2026 · Updated 28 times

Summary

This study tested whether a numbing cream (ropivacaine) can reduce severe pain during bath and dressing changes in children and young adults with epidermolysis bullosa, a rare genetic skin condition. Ten participants applied the cream before dressing changes and reported their pain levels. The goal was to see if pain scores dropped by at least 2 points over five days, aiming to improve quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEREDITARY EPIDERMOLYSIS BULLOSA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hôpital Necker Enfants Malades

    Paris, 75015, France

Conditions

The condition(s) this trial relates to.

epidermolysis bullosa inherited epidermolysis bullosa Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.